🔎 Trials Near Me

Dachaigh › Lymphoma Cealla-B › Massachusetts

Sgrùdaidhean clionaigeach Lymphoma Cealla-B ann an Massachusetts

Tha 8 sgrùdaidhean airson Lymphoma Cealla-B a’ lorg phàirtichean aig làraichean ann an Massachusetts.

Bailtean ann an Massachusetts

Teacsa sgrùdaidh oifigeil (Beurla)

A Study to Investigate the Efficacy and Safety of Sonrotoclax Plus Zanubrutinib Compared With Placebo Plus Zanubrutinib in Adults With Relapsed/Refractory Mantle Cell Lymphoma (CELESTIAL-RRMCL)

  • Dana Farber Cancer Institute Longwood Medical Center, Boston
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 28 Sult 2026 · NCT06742996

A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )

  • Massachusetts General Hospital, Boston
  • Dana-Farber Cancer Institute, Boston
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 22 Sult 2026 · NCT07101328

A Study of AZD0486 Monotherapy or in Combination With Other Anti-Cancer Agents for Mature B-Cell Malignancies

  • Research Site, Boston
A’ fastadhÌre 1/2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 8 Sult 2026 · NCT06564038

A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas

  • Massachusetts General Hospital, Boston
A’ fastadhÌre 1/2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 19 Lùna 2026 · NCT04104776

DALY II USA/ MB-CART2019.1 for DLBCL

  • Dana Farber Cancer Institute, Boston
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 13 Iuch 2026 · NCT04792489

CD79b-19 CAR T Cells in Non-Hodgkin Lymphoma

  • Massachusetts General Hospital, Boston
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 16 Màrt 2026 · NCT06026319

Study Evaluating UCART20x22 in B-Cell Non-Hodgkin Lymphoma

  • Harvard Medical School - Massachusetts General Hospital, Boston
A’ fastadhÌre 1/2
Aoisean 18 gu 80 · Gach gnè · Air ùrachadh 24 Lùna 2025 · NCT05607420

Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies

  • Dana-Farber Cancer Institute, Boston
A’ fastadhÌre 1
Aoisean 1 gu 21 · Gach gnè · Air ùrachadh 6 Dùbh 2024 · NCT05476770

Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.